| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences Inc (NBIX) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 514.6K | $76.98M | - | |
| CEO | 140.4K | $21.00M | - | |
| Other | 70.1K | $10.49M | - | |
| Dir | 40.4K | $6.04M | - | |
| Dir | 34.5K | $5.16M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Norwalk Leslie V64 | Director | Sale+OE | 6,190 | $152.78 | $945,701.91 | -31.2% | -12.7% | - | |
| Dec 8, 2025 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 4,376 | $159.65 | $698,615.27 | -9.2% | -16.2% | - | |
| Dec 3, 2025 | Lyons Gary A54 | Director | Sale+OE | 15,000 | $152.61 | $2,289,082.50 | -11.1% | -13.7% | - | |
| Nov 28, 2025 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 5,970 | $151.74 | $905,880.64 | -11.7% | -14.1% | - | |
| Nov 25, 2025 | Morrow George J71 | Director | Sale+OE | 15,000 | $143.37 | $2,150,512.50 | -68.0% | -10.5% | - | |
| Nov 5, 2025 | Rastetter William H49 | Director | Sale+OE | 18,000 | $151.82 | $2,732,689.80 | -30.8% | -9.6% | - | |
| Nov 4, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 300 | $141.97 | $42,591.00 | -0.2% | -3.9% | - | |
| Aug 7, 2025 | Gorman Kevin Charles56 | Director | Sale+OE | 106,322 | $126.41 | $13,440,280.97 | -17.1% | +22.4% | - | |
| Jul 10, 2025 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 457 | $135.00 | $61,695.00 | -8.8% | +3.1% | - | |
| Jul 9, 2025 | Onyia Jude54 | Chief Scientific Officer | Sale+OE | 59,819 | $130.46 | $7,803,687.65 | -76.6% | +2.6% | - |